Ilan Daskal - Sep 1, 2023 Form 4 Insider Report for BIO-RAD LABORATORIES, INC. (BIO)

Role
EVP, Chief Financial Officer
Signature
/s/ Ilan Daskal
Stock symbol
BIO
Transactions as of
Sep 1, 2023
Transactions value $
-$283,323
Form type
4
Date filed
9/6/2023, 01:00 PM
Previous filing
Apr 11, 2023
Next filing
Nov 14, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +694 +45.89% $0.00 2.21K Sep 1, 2023 Direct F1, F2
transaction BIO Bio-Rad A Common Stock Tax liability -$94.7K -240 -10.88% $394.60 1.97K Sep 1, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +456 +23.19% $0.00 2.42K Sep 1, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$82.5K -209 -8.63% $394.60 2.21K Sep 1, 2023 Direct
transaction BIO Bio-Rad A Common Stock Options Exercise $0 +542 +24.49% $0.00 2.76K Sep 2, 2023 Direct F1
transaction BIO Bio-Rad A Common Stock Tax liability -$106K -269 -9.76% $394.60 2.49K Sep 2, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BIO Restricted Stock Units Award $0 +4.01K $0.00 4.01K Sep 1, 2023 Bio-Rad A Common Stock 4.01K $0.00 Direct F3, F4
transaction BIO Restricted Stock Units Options Exercise $0 -694 -25% $0.00 2.08K Sep 1, 2023 Bio-Rad A Common Stock 694 $0.00 Direct F3, F5
transaction BIO Restricted Stock Units Options Exercise $0 -456 -33.33% $0.00 912 Sep 1, 2023 Bio-Rad A Common Stock 456 $0.00 Direct F3, F6
transaction BIO Restricted Stock Units Options Exercise $0 -542 -50% $0.00 542 Sep 2, 2023 Bio-Rad A Common Stock 542 $0.00 Direct F3, F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares of Class A common stock acquired on the vesting of restricted stock units.
F2 Includes 18.9440 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 06/30/2023.
F3 Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F4 The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant.
F5 On September 1, 2022, the reporting person was granted 2,776 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F6 On September 1, 2021, the reporting person was granted 1,823 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.
F7 On September 2, 2020, the reporting person was granted 2,166 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date.